Prevalence of hepatitis B infection among schoolchildren in southeast turkey

Turkish Journal of Medical Sciences

Volumn 39, Issue 2, 2009, Pages 289-293

  Dikici, Bünyamin ^a   Uzun, Hakan ^a   Gözü, Ayfer ^b   Fidan, Mücahit ^b  

^a DUZCE UNIVERSITY   (Turkey)

^b DICLE UNIVERSITY   (Turkey)

Author keywords

Hepatitis B; Prevalence; Vaccine

Indexed keywords

BLOOD SAMPLES; ENZYME LINKED IMMUNO-SORBENT ASSAYS; HEPATITIS B; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; MEAN AGES; PREVALENCE; SYSTEMATIC SAMPLINGS;

ANTIBODIES;

ANTIGENS;

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN;

ADOLESCENT; ARTICLE; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PREVALENCE; SCHOOL CHILD; SEROPREVALENCE; TURKEY (REPUBLIC);

EID: 65249086795     PISSN: 13000144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Kane MA. Global status of hepatitis B immunization. Lancet 1996; 348: 696.
2. Global distribution of Hepatitis B. Introduction of hepatitis B vaccine into childhood immunization: World Health Organization, Geneva, Switzerland 2001. Available from: URL: http://www.who.int/vaccines-documents/DocsPDF01/ www613.pdf
3. Margolis HS, Alter MJ, Hadler SC. Hepatitis B: Evolving epidemiology and implications for control. Semin Liver Dis 1991; 11: 84-92.
4. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet 1981; 21: 1129-33.
5. Yu AS, Cheung RC, Keeffe EB. Hepatitis B Vaccine Clin Liver Dis 2004; 8: 283-300.
6. Chang MH. Decreasing incidence of hepatocellular carcinoma among children following universal hepatitis B immunization. Liver Int 2003; 23: 309-14.
7. Expanded program on immunization. Global Advisory Group-Part II. Weekly Epidemiological Record 1991; 66: 9-12.
8. World Health Organization. WHO Vaccine Preventable Diseases Monitoring System: 2006 Global Summary. Geneva, Switzerland, 2006. Available from: URL: http://www.who.int/vaccines-documents/GlobalSummary/GlobalSummary.pdf
9. Doganci L, Haznedaroglu T. Prevalence of hepatitis A, B and C in Turkey. Eur J Clin Microbiol Infect Dis 1992; 11: 661-2.
10. Beasley RP, Hwang LY. Postnatal infectivity of hepatitis B surface antigen-carrier mothers. J Infect Dis 1983; 147: 185-90.
11. Stevens CE, Neurath RA, Beasley RP, Szmuness W. HBeAg and anti-HBe detection by radioimmunoassay: Correlation with vertical transmission of hepatitis B in Taiwan. J Med Virol 1979; 3: 237-41.
12. Namgyal P. Impact of hepatitis B immunization, Europe and worldwide. J Hepatol 2003; 39: 77-82.
13. Poovorawan Y, Theamboonlers A, Vimolket T, Sinlaparatsamee S, Chaiear K, Siraprapasiri T et al. Impact of hepatitis B immunisation as part of the EPI. Vaccine 2000; 22: 943-9.
14. Andre F. Hepatitis B epidemiology in Asia, the Middle East and Africa. Vaccine 2000; 18: 20-2.
15. Ghavanini AA, Sabri MR. Hepatitis B surface antigen and anti- hepatitis C antibodies among blood donors in the Islamic Republic of Iran. East Mediterr Health J 2000; 6: 1114-16.
16. Ayoola AE, Tobaigy MS, Gadour MO, Ahmad BS, Hazma MK, Ageel AM. The decline of hepatitis B viral infection in SouthWestern Saudi Arabia. Saudi Med J 2003; 24: 991-5.
17. Papaevangelou G, Roumeliotou A, Chatziminas M, Kotsianopoulou M, Ioannou P, Trichopoulou E et al. Epidemiological characteristics of hepatitis B virus infection in Cyprus. Eur J Epidemiol 1988; 4: 150-3.
18. Butsashvili M, Tsertsvadze T, McNutt LA, Kamkamidze G, Gvetadze R, Badridze N. Prevalence of hepatitis B, hepatitis C, syphilis and HIV in Georgian blood donors. Eur J Epidemiol 2001; 17: 693-5.
19. Kanra T, Pirnar A. Hepatitis Bs-antigen among blood donors in Ankara. Turk J Pediatr 1979; 21: 1-3.
20. Erden S, Buyukozturk S, Calangu S, Yilmaz G, Palanduz S, Badur S. A study of serological markers of hepatitis B and C viruses in Istanbul, Turkey. Med Princ Pract 2003; 12: 184-8
21. Ariogul S, Akalin E, Kanra T. HBsAg among Turkish blood donors. Infection 1987; 15: 456.
22. Aydin F, Cubukgu K, Yetiskul S, Yazici Y, Kaklikkaya N. Retrospective evaluation of HBsAg, anti-HCV, anti-HIV and syphilis reagin antibody seropositivity in blood donors at the Trabzon Farabi Hospital. Mikrobiyol Bul 2002; 36: 85-90.
23. Tsen YJ, Chang MH, Hsu HY, Lee CY, Sung JL, Chen DS. Seroprevalence of hepatitis B virus infection in children in Taipei, 1989: five years after a mass hepatitis B vaccination program. J Med Virol 1991; 34: 96-9.
24. Chen HL, Chang MH, Ni YH, Hsu HY, Lee PI, Lee CY et al. Seroepidemiology of hepatitis B virus infection in children: Ten years of mass vaccination in Taiwan. JAMA 1996; 276: 906-8.
25. Karna G, Tezcan S, Badur S, Turkish National Study Team. Hepatitis B and Measles seroprevalence among Turkish Children. Turk J Pediatr 2005; 47: 105-10.
26. Doganci T, Uysal G, Kir T, Bakirtas A, Kuyucu N, Doganci L. Horizontal transmission of hepatitis B virus in children with chronic hepatitis B. World J Gastroenterol 2005; 21: 418-20.
27. Erol S, Ozkurt Z, Ertek M, Tasyaran MA. Intrafamilial transmission of hepatitis B virus in the eastern Anatolian region of Turkey. Eur J Gastroenterol Hepatol. 2003; 15: 345-9.
28. Koff RS. Vaccines and hepatitis B. Clin Liver Dis 1999; 3: 417-28.